Stem Cell Therapy Gets Fast Track Status for Parkinson Disease
DA01 is an investigational pluripotent stem cell-derived dopaminergic neuron therapy designed to replace the midbrian dopaminergic neurons lost in Parkinson disease.
Treatments
Relapse Risk for Psychosis in Dementia Lower With Continued Pimavanserin
For patients with dementia-related psychosis who have a response to pimavanserin, the risk for relapse is lower with continuation of the drug versus discontinuation
Broad Range of Drug-Drug Interactions in Migraine Prevention and Treatment
Researchers conducted a narrative review of the pharmacokinetics of major classes of migraine preventives and the implications of drug-drug interactions in treatment.
Evaluating Transcranial Magnetic Stimulation Technologies: Deep vs Traditional
Patients with depression can live with symptoms for a long period of time before finding an option that works. One possibility for patients who are unable to find relief through pharmacology is transcranial magnetic stimulation. An expert offers his view on this form of treatment.
Targeted Therapy for Recurrent Seizure-Related GRIN1 Variant
This case study detailed a pediatric patient with drug-resistant seizures and early-onset epileptic encephalopathy who carried a GRIN1 variant.
FDA Approves Spinal Cord Stimulation Therapy for Painful Diabetic Neuropathy
The FDA has approved the Senza® Omnia spinal cord stimulation system for the treatment of chronic pain associated with PDN.
Two Major Health Systems Will Not Administer Controversial Aduhelm
Individual doctors can prescribe Aduhelm, but patients would have to go elsewhere to receive the drug via infusion
Impact of Alemtuzumab on the Visual System in Patients with Multiple Sclerosis
Study investigators used the visual pathway to assess the promyelinating and neuroprotective effects of alemtuzumab in multiple sclerosis.
First Alzheimer Disease Prevention Trial Using Amyloid-Targeting Drugs Gantenerumab or Solanezumab
The researchers conducted a randomized, placebo-controlled, multi-arm trial of gantenerumab or solanezumab in participants with dominantly inherited Alzheimer disease across asymptomatic and symptomatic disease stages.
Low-Intensity Focused Ultrasound May Safely, Effectively Treat Chemo-Induced Peripheral Neuropathy
The researchers’ goal was to evaluate the effectiveness of low-intensity focused ultrasound (LIFU) therapy in the management of cancer-related neuropathic pain (CNP).
- Loading...
Loading...
Next post in Neuropathy
Loading... 
Loading...